Choosing the surgical treatment method for benign prostatic hyperplasia

Abstract

Aim. To assess the surgical treatment outcomes for benign prostatic hyperplasia. Methods. The surgical treatment outcomes for benign prostatic hyperplasia were analyzed in 72 patients. 44 patients underwent transvesical prostatectomy ended with blind urinary bladder stitch, 28 patients with a prostate volume of less than 60 ml were offered transurethral resection of prostate. The patients’ mean age was 73.6 years. Inclusion criteria were: average urination flow rate (Qav) <10 ml/sec, total international prostate symptom score (I-PSS) >19, residual urine volume >50 ml. Prostate volume ranged from 29 to 150 ml. All interventions were performed using regional anesthesia. The effect of surgical treatment was assessed 3 months after the surgery was performed. Results. Self urination was restored at 2-3rd day. All patients had no residual urine. Urine flow parameters in patients after transvesical prostatectomy were: maximum urination flow rate (Qmax) - 24±1.3 ml/sec, Qav - 11.6±1.1 ml/sec; in patients after transurethral resection of prostate: Qmax - 17.2±0.8 ml/sec, Qav - 11.4±1.2 ml/sec. I-PSS index in the transvesical prostatectomy group was 2.3±0.3 compared to 9.7±1.1 points in transurethral resection of prostate group. Irritative symptoms prevailed in patients from transurethral resection of prostate group, 23 (82%) of them have improved after 1 month treatment with α1-adrenoblockers. Conclusion. Transvesical prostatectomy ended with blind urinary bladder stitch is still a radical and effective option for benign prostatic hyperplasia surgical treatment. Transurethral resection of prostate is effective in patients with prostate volume less than 60 ml and requires additional medical correction of irritative symptoms during the postoperative period.

Keywords

benign prostatic hyperplasia / transvesical prostatectomy / transurethral resection of prostate

References

[1] Гориловский Л.М. Заболевания предстательной железы в пожилом возрасте. - М.: Медпрактика, 1999. - С. 4-14.

[2] Лоран О.Б., Лукьянов И.В., Марков А.В. Комплексная терапия ирритативных расстройств мочеиспускания после оперативного лечения доброкачественной гиперплазии предстательной железы с применением АПК «Андро-Гин» // Урология. - 2005. - №3. - С. 15-18.

[3] Ситдыков Э.Н., Басиашвили Т.Г., Ситдыкова М.Э. Обструктивные и воспалительные осложнения аденомэктомии предстательной железы, их профилактика и лечение. - Казань, 1995. - 54 с.

[4] Jepsen J.V., Bruskewitz R.C. Recent developments in the surgical management of benign prostatic hyperplasia // Urology. - 1998. - Vol. 51. - P. 23-31.

[5] Kim T.I., Song J.M., Chung H.C. Analysis of the factors causing bladder irritation after transurethral resection of the prostate // Korean J. Urol. - 2010. - Vol. 51. - P. 700-703.

[6] Kuntz R.M., Lehrich K., Ahyai S.A. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial // Eur. Urol. - 2008. - Vol. 53. - P. 160-166.

[7] Madersbacher S., Lackner J., Brossner C. et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nationwide, long-term analysis of 23,123 cases // Eur. Urol. - 2005. - Vol. 47. - P. 499-504.

[8] McConnell J.D., Barry M.J., Bruskewitz R.C. et al. Benign prostatic hyperplasia: diagnosis and treatment. Quick reference guide for clinicians. - Rockville, 1994. - P. 1-17.

[9] Meyhoff H.H., Nordling J., Hald T. Urodynamics evalution of transurethral versus transvesical prostatectomy // Scand. J. Urol. Nephrol. - 1984. - Vol. 18. - P. 27-35.

[10] Meyhoff H.H., Nordling J. Long term results of transurethral and transvesical prostatectomy. A randomized study // Scand. J. Urol. Nephrol. - 1986. - Vol. 20. - P. 27-33.

[11] Nasser S., Hamidreza A., Amir H.K. et al. Open prostatectomy versus transurethral resection of the prostate, where are we standing in the new era? A randomized controlled trial // Urol. J. - 2010. - Vol. 7. - P. 262-269.

[12] Rassweiler J., Teber D., Kuntz R., Hofmann R. Complications of transurethral resection of the prostate (TURP) - incidence, management, and prevention // Eur. Urol. - 2006. - Vol. 50. - P. 969-980.

[13] Schroder F., Altwein I. Benign prostatic hyperplasia. A diagnosis and treatment primer. - Oxford, 1992. - P. 31-50.

[14] Tubaro A., Carter S., Hind A. et al. A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia // J. Urol. - 2001. - Vol. 166. - P. 172-176.

[15] Varkarakis I., Kyriakakis Z., Delis A. Long-term results of open transvesical prostatectomy from a contemporary series of patients // Urology. - 2004. - Vol. 64. - P. 306-310.

RIGHTS & PERMISSIONS

Sitdykov R.M., Shaidullin E.N., Zubkov A.Y.